OPIANT PHARMACEUTICALS INC (OPNT)
US6837501039 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.38M | 37.85M | 48.25M | 30.98M | 24.61M | |||
| Marketable Securities | 0.00 | 15.01M | N/A | N/A | N/A | |||
| Receivables | 41.11K | 13.33M | 8.91M | 7.22M | 4.49M | |||
| Other Current Assets | 3.13M | 2.96M | 1.94M | 1.06M | 270.00K | |||
| Total Current Assets | 38.55M | 69.16M | 59.10M | 39.25M | 29.37M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.16M | 1.08M | 450.00K | 1.01M | 0.00 | |||
| Intangibles | 10.60K | 11.63K | 10.00K | 10.00K | 20.00K | |||
| Other Non-Current Assets | 234.39K | 179.53K | 1.05M | N/A | N/A | |||
| Total Non-Current Assets | 3.40M | 1.27M | 1.51M | 1.03M | 20.00K | |||
| TOTAL ASSETS | 41.95M | 70.43M | 60.61M | 40.28M | 29.39M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.44M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 2.49M | 538.94K | 1.19M | 1.75M | 1.08M | |||
| Accounts Payable | 3.11M | 3.37M | 2.97M | 1.32M | 1.13M | |||
| Other Current Liabilities | 0.00 | 2.94M | 2.26M | 2.54M | 7.61M | |||
| Total Current Liabilities | 7.04M | 6.85M | 6.42M | 5.61M | 9.83M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 12.32M | 16.07M | 18.70M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.08M | 673.35K | 0.00 | 250.00K | 2.70M | |||
| Total Non-Current Liabilities | 14.41M | 16.74M | 18.70M | 250.00K | 2.70M | |||
| TOTAL LIABILITIES | 21.45M | 23.59M | 25.12M | 5.86M | 12.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -95.52M | -61.68M | -64.69M | -62.83M | -74.42M | |||
| Additional Paid In Capital | 116.27M | 108.57M | 100.20M | 97.24M | 91.28M | |||
| Common Shares | 5.17K | 4.91K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -248.13K | -54.82K | -30.00K | N/A | N/A | |||
| Shares Outstanding | 5.16M | 4.91M | 4.26M | 4.19M | 3.85M | |||
| Tangible Book Value per Share | 3.97 | 9.54 | 8.33 | 8.21 | 4.37 | |||
| Total Shareholders' Equity | 20.50M | 46.84M | 35.49M | 34.42M | 16.86M | |||
| TOTAL LIABILITIES AND EQUITY | 41.95M | 70.43M | 60.61M | 40.28M | 29.39M | |||
| Statistics | ||||||||
| Debt/Equity | 0.60 | 0.34 | 0.53 | N/A | N/A | |||
| Current Ratio | 5.48 | 10.10 | 9.21 | 7.00 | 2.99 | |||
| Return On Assets (ROA) | -78.88% | 4.27% | -3.07% | 28.77% | -72.13% | |||
| Return On Equity (ROE) | -161.39% | 6.42% | -5.24% | 33.67% | -125.74% | |||
| Return On Invested Capital (ROIC) | N/A | 6.41% | N/A | 24.86% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 38.02% | N/A | 233.57% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 38.06% | N/A | 234.21% | N/A | |||
All data in USD